source
- Analyst doubts gold-based ALS therapy from Clene, calling it ineffectiveAdam Feuerstein, a senior biotech writer, published a piece in his Biotech Scorecard newsletter questioning a new ALS treatment. The company Clene is developing CNM-Au8, which it describes as a hi…
- Hospital shootings have risen steadily since 2000, according to new dataA new analysis shows that incidents of gunfire inside U.S. hospitals have been climbing each year since 2000. The report notes a clear upward trend in the frequency of these events, raising concer…